Stephen W. Beard

CVSA Chairman & CEO Beard sells 5,291 shares for $690,197.88 under pre-arranged 10b5-1 plan

Stephen W. Beard sold 5,291 shares across 2 separate transactions on June 10–11, 2026, at prices of $130.14 and $130.78 (blended average $130.45), generating $690,197.88 in proceeds. This sale represents a -1.2% reduction from his pre-transaction holdings of 429,324 shares, leaving him with 424,033 shares post-transaction. The sale was part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-10, meaning the transactions were scheduled rather than discretionary. At the time of sale, CVSA's stock was trading near recent highs (within 4.0% of its 52-week high of $133.74), and the company shows solid fundamentals with $487.0M quarterly revenue, $41.6M net income, and 12.8% annual revenue growth. The scheduled nature of the sale precludes any timing characterization, and the modest portfolio reduction (1.2%) does not signal a significant shift in the CEO's stake at a company showing positive earnings and growth momentum.

Chairman & CEO Stephen Beard sells ~16K shares for $2.1M, his first open-market sale in 3 years.

Stephen Beard, Chairman & CEO of Covista, executed his first open-market sale in the past three years, disposing of roughly 3.6% of his holdings for just over $2M. The sale occurred when the stock was trading slightly below its 52-week high, having rallied meaningfully over the preceding month. Covista itself remains fundamentally sound—profitable with growing revenue and a reasonable valuation—so the sale does not reflect financial distress at the company level. Without prior open-market purchases or sales on record, this transaction marks a clear shift from Beard's documented activity, which had consisted entirely of stock-based compensation awards. The timing and size warrant attention as an indicator of the Chairman's current capital allocation priorities, though the absence of a broader pattern of insider selling provides no corroboration of concern at the board level.